A Community-Based Intervention to Reduce Alcohol Use in Vietnamese Men
Launched by CHULALONGKORN UNIVERSITY · Nov 27, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a program designed to help Vietnamese men reduce their alcohol use. The study will involve 104 men, aged 35-44, who have been identified as having hazardous alcohol use, which means they are drinking at levels that could harm their health. Participants will be randomly assigned to either a group that receives a special community-based program aimed at helping them use protective strategies for drinking or a control group that will only receive usual care for their alcohol use. The program includes five weekly sessions, each lasting 90 minutes, along with text message reminders to help participants stay on track.
To be eligible for the study, men must have a specific score indicating their level of alcohol use, have completed at least primary school, speak Vietnamese, own a mobile phone, and be willing to participate. Those who also use illicit drugs or have serious health or mental health issues will not be included. The main goal of the trial is to see if this program can lower the amount and frequency of alcohol consumption over three months, as well as reduce alcohol-related problems and intentions to drink. This study is not yet recruiting participants, but it aims to provide valuable insights into effective ways to help individuals manage their alcohol use in their communities.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Having a total AUDIT score from 8 to 15
- • Completing at least primary school
- • Able to use the Vietnamese language
- • Having a mobile phone
- • Willing to participate in this study
- Exclusion Criteria:
- • Using alcohol and other illicit drugs at the same time
- • Having any physical illness or psychiatric disorders
About Chulalongkorn University
Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, Bangkok, Thailand, Thailand
Bangkok, , Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported